Clinical Trial for Patients Who Have Had a Recent Heart Attack
Cell Center of the Texas Heart Institute at St. Luke's Medical Center in
Houston, Texas is actively recruiting patients for FDA-approved clinical
studies investigating the use of stem cells in aiding with recovery after a
Acute myocardial infarction (heart attack)
occurs when an artery that feeds the heart (coronary artery) becomes blocked
and blood flow to that area of the heart is cut off leading to muscle
damage. The usual course of therapy is to be admitted to a hospital, open
the blocked artery with a balloon, stent, or surgical bypass, then placed on
medicines hoping the heart will recover.
The Stem Cell Center is enrolling patients who have had a recent heart attack and were treated with balloon/stents in order to see if stem cell therapy would
aid in the recovery of heart muscle.
Main Inclusion Criteria
- Patients must be 18 years or older.
- Patients must be screened for eligibility immediately after heart attack.
- Patients must have had a specific type of heart attack called STEMI.
- Patients need to have had a stent placed in one of the arteries of the heart within 3 days of chest pain onset that resulted in restoration of blood flow.
If you are a patient who wishes to be considered for this study please call us toll free at 1-866-924-STEM (7836), or complete our secure online Patient Information Form.
If you are a Physician and would like to refer a patient for consideration, please contact a study coordinator at 832-355-9405.